The synthesis of a range of pentylbezene- 1,3-diol compounds of formula I is disclosed. These compounds bind to cannabinoid 1 and 2 receptors (CB1 and CB2), and are thus presumed to be useful in modulating the activity of such receptors. Accordingly, the use of such synthetic cannabinoids in the treatment of various disorders mediated by CB1 and CB2 is contemplated.
揭示了一系列式I的
戊基苯-1,3
-二醇化合物的合成。这些化合物与
大麻素1和2受体(CB1和CB2)结合,因此被认为在调节这些受体的活性方面是有用的。因此,考虑了在治疗由CB1和CB2介导的各种疾病中使用这种合成
大麻素。